Defunct Company
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
481
NCT01243502
A Study to Assess the Pharmacokinetics, Safety and Tolerability of CT327 in Healthy Male Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 30, 2007
Completion: Nov 30, 2007
NCT00996008
CT 327 in the Treatment of Atopic Dermatitis
Phase: Phase 2
Start: Nov 30, 2009
Completion: Oct 31, 2010
NCT00995969
CT 327 in the Treatment of Psoriasis Vulgaris
Start: Mar 31, 2010
Completion: Jan 31, 2011
NCT01243307
A Study to Investigate the Pharmacodynamic Effects of CT327 on Intra-dermal Nerve Growth Factor (NGF) and Evoked Pain Responses, in Healthy Male Volunteers
Start: Jan 31, 2011
Completion: May 31, 2011
NCT01465282
Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris
Start: Dec 31, 2011
Completion: Sep 30, 2012
NCT01808157
A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis
Start: Jul 31, 2013
Completion: Apr 30, 2014